These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 25245127)
61. A comprehensive review of childbearing after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Papageorgiou D; Manatakis DK; Papakonstantinou K; Kyriazanos ID Arch Gynecol Obstet; 2020 Oct; 302(4):793-799. PubMed ID: 32653946 [TBL] [Abstract][Full Text] [Related]
62. Incidence, Risk Factors, and Prevention Strategies for Venous Thromboembolism after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Khan S; Kelly KJ; Veerapong J; Lowy AM; Baumgartner JM Ann Surg Oncol; 2019 Jul; 26(7):2276-2284. PubMed ID: 31065960 [TBL] [Abstract][Full Text] [Related]
63. Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Canda AE; Sokmen S; Terzi C; Arslan C; Oztop I; Karabulut B; Ozzeybek D; Sarioglu S; Fuzun M Ann Surg Oncol; 2013 Apr; 20(4):1082-7. PubMed ID: 23456387 [TBL] [Abstract][Full Text] [Related]
64. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? Chia CS; You B; Decullier E; Vaudoyer D; Lorimier G; Abboud K; Bereder JM; Arvieux C; Boschetti G; Glehen O; Ann Surg Oncol; 2016 Jun; 23(6):1971-9. PubMed ID: 26753751 [TBL] [Abstract][Full Text] [Related]
65. Hepatectomy for metachronous colorectal liver metastases following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal metastases: a report of three cases. Ito K; Takemura N; Inagaki F; Mihara F; Kurokawa T; Gohda Y; Kiyomatsu T; Yano H; Kokudo N World J Surg Oncol; 2019 Jun; 17(1):99. PubMed ID: 31196097 [TBL] [Abstract][Full Text] [Related]
66. Genitourinary resection at the time of cytoreductive surgery and heated intraperitoneal chemotherapy for peritoneal carcinomatosis is not associated with increased morbidity or worsened oncologic outcomes: a case-matched study. Leapman MS; Jibara G; Tabrizian P; Franssen B; Yang MJ; Romanoff A; Hall SJ; Palese M; Sarpel U; Hiotis S; Labow D Ann Surg Oncol; 2014 Apr; 21(4):1153-8. PubMed ID: 24322531 [TBL] [Abstract][Full Text] [Related]
67. Surgical and oncological outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy at a nonacademic center: 25-year experience. Nikiforchin A; Gushchin V; King MC; Baron E; Nieroda C; Sittig M; Sardi A J Surg Oncol; 2021 Mar; 123(4):1030-1044. PubMed ID: 33524164 [TBL] [Abstract][Full Text] [Related]
68. [Surgical Management of Peritoneal Surface Malignancy with Respect to Tumour Type, Tumour Stage and Individual Tumour Biology]. Beckert S; Struller F; Grischke EM; Glatzle J; Zieker D; Königsrainer A; Königsrainer I Zentralbl Chir; 2016 Aug; 141(4):415-20. PubMed ID: 24241953 [TBL] [Abstract][Full Text] [Related]
69. Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study. Maillet M; Glehen O; Lambert J; Goere D; Pocard M; Msika S; Passot G; Elias D; Eveno C; Sabaté JM; Lourenco N; André T; Gornet JM; Ann Surg Oncol; 2016 Mar; 23(3):863-9. PubMed ID: 26480848 [TBL] [Abstract][Full Text] [Related]
70. Feasibility of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced peritoneal surface tumors during the COVID-19 pandemic: A single-institution experience. Radomski SN; Florissi I; Khan H; Siddiqi A; Paneitz DC; Johnston FM; Greer JB J Surg Oncol; 2022 Dec; 126(8):1375-1382. PubMed ID: 36081374 [TBL] [Abstract][Full Text] [Related]
71. Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): a Single-Center Experience in Austria. Pamela K; Matthias Z; Reinhold KR; Julia P; Peter M; Alexander P; Dietmar Ö J Gastrointest Surg; 2018 May; 22(5):884-893. PubMed ID: 29363016 [TBL] [Abstract][Full Text] [Related]
72. Trends in Outcomes After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy. Gani F; Conca-Cheng AM; Nettles B; Ahuja N; Johnston FM J Surg Res; 2019 Feb; 234():240-248. PubMed ID: 30527480 [TBL] [Abstract][Full Text] [Related]
73. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution. Teo MC; Tan GH; Tham CK; Lim C; Soo KC Ann Surg Oncol; 2013 Sep; 20(9):2968-74. PubMed ID: 23504144 [TBL] [Abstract][Full Text] [Related]
74. What made hyperthermic intraperitoneal chemotherapy an effective curative treatment for peritoneal surface malignancy: A 25-year experience with 1,125 procedures. Passot G; Vaudoyer D; Villeneuve L; Kepenekian V; Beaujard AC; Bakrin N; Cotte E; Gilly FN; Glehen O J Surg Oncol; 2016 Jun; 113(7):796-803. PubMed ID: 27110915 [TBL] [Abstract][Full Text] [Related]
75. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for endometrial cancer-derived peritoneal metastases: a systematic review. Tempfer CB; Kern P; Dogan A; Hilal Z; Rezniczek GA Clin Exp Metastasis; 2019 Aug; 36(4):321-329. PubMed ID: 31089843 [TBL] [Abstract][Full Text] [Related]
76. Routine Admission to Intensive Care Unit After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy: Not Always a Requirement. Mogal HD; Levine EA; Fino NF; Obiora C; Shen P; Stewart JH; Votanopoulos KI Ann Surg Oncol; 2016 May; 23(5):1486-95. PubMed ID: 26572753 [TBL] [Abstract][Full Text] [Related]
77. Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes. Sardi A; Jimenez WA; Nieroda C; Sittig M; Macdonald R; Gushchin V Eur J Surg Oncol; 2013 Nov; 39(11):1207-13. PubMed ID: 24007834 [TBL] [Abstract][Full Text] [Related]
78. Postoperative outcomes of laparoscopic vs open cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for treatment of peritoneal surface malignancies. Passot G; Bakrin N; Isaac S; Decullier E; Gilly FN; Glehen O; Cotte E Eur J Surg Oncol; 2014 Aug; 40(8):957-62. PubMed ID: 24209429 [TBL] [Abstract][Full Text] [Related]
79. [CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL CARCINOMATOSIS OF COLORECTAL ORIGIN - FIRST 100 CASES]. Berger Y; Jacoby H; Zager Y; Lebedyev A; Gutman M; Hoffman A Harefuah; 2019 Apr; 158(4):227-232. PubMed ID: 31032553 [TBL] [Abstract][Full Text] [Related]
80. Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study. Yu P; Ye Z; Dai G; Zhang Y; Huang L; Du Y; Cheng X BMC Cancer; 2020 Nov; 20(1):1108. PubMed ID: 33198674 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]